China's Sinopharm Covid vaccine claims effectiveness over South African Covid variant

▴ China's Sinopharm Covid vaccine claims effectiveness over South African Covid variant
Chinese vaccine company using live virus vaccine claims efficacy over mutated Covid strain

China’s Sinopharm Covid-19 vaccine can inactivate a worrying coronavirus variant first identified in South Africa, researchers from the Chinese Center for Disease Control and Prevention said Tuesday.

Their study is published online as a pre-print, meaning it has not been peer-reviewed and includes few details.

Sinopharm’s vaccine, which the company says has been given to 10 million people across China, is a “live” virus vaccine -- meaning it's made using a whole virus that has been inactivated so it cannot cause disease.

The team said they tested 12 samples taken from people who got the Sinopharm vaccine, and 12 samples from volunteers who received an experimental vaccine, against the variant virus.

Both vaccines elicited enough antibodies to neutralize the virus and overcome its mutation, they said.

“These data indicated that (the variant) will not escape the immunity induced by vaccines targeting whole virus or RBD,” the researchers wrote.


The mutation, explained: The virus has a structure called the receptor binding domain, or RBD, which it uses to dock onto cells and infect them. The RBD is the mutated part of the new variant that makes it different from the original strand.

Many coronavirus vaccines, including those made by Pfizer and Moderna, specifically target the RBD -- but a live virus vaccine-like Sinopharm's is less specific.

Tags : #Sinopharma #Pfizer #Moderna #SouthAfricanCovidVariant #RBD #LiveVirusVaccine #ChinaNews #ChineseCentreforDiseaseControlAndPrevention

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026